Representing CAPRISA at the 2018 HIVR4P in Madrid

31 October 2018

CAPRISA collaborators and researchers participated in several sessions at the 2018 HIVR4P conference held in Madrid, Spain from 21 – 25 October where the latest biomedical prevention research was presented. The presentations by CAPRISA focused largely on broadly neutralizing antibodies and vaccine research. One of the highlights at the conference was understanding how to tweak the broadly neutralizing antibody structural characteristics itself to better preserve function and half-life for translational passive immunization studies in humans to prevent HIV.

 Invited speakers included Profs Lynn Morris and Penny Moore, CAPRISA honorary senior scientists, and NICD Postdoctoral Fellow, Dr Simone Richardson. Morris delivered a talk entitled, “Antibody Mediated Protection (AMP): Where Are We? Which Antibodies to Use and How Will We Know If It´s Working?” and Moore presented two talks at satellite sessions entitled: “The impact of antibody isotype on neutralization” and “Broadly neutralizing antibodies in HIV-infected children”.  Richardson’s talk in a satellite session was entitled: “The Link Between Fc Effector Function and Neutralization”.

CAPRISA-affiliated researchers were represented in 8 oral and 13 poster presentations (Box 1). CAPRISA scientist Dr Sinaye Ngcapu chaired the oral poster session entitled: “Microbiome: When Microorganisms and the Immune System Meet.”

 Access the full list of CAPRISA presentations in the October newsletter at: